Neurocrine Biosciences Inc (NBIX)

Financial leverage ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total assets US$ in thousands 3,251,400 2,848,200 2,613,100 2,359,800 2,368,700 2,143,400 2,005,700 2,144,500 2,072,500 2,017,300 1,956,400 1,846,400 1,734,700 1,502,600 1,515,600 1,361,900 1,306,000 1,179,940 1,066,860 957,723
Total stockholders’ equity US$ in thousands 2,232,000 2,002,100 1,853,000 1,684,500 1,707,800 1,544,600 1,423,400 1,391,100 1,374,000 1,346,000 1,279,200 1,205,600 1,126,200 804,300 831,200 700,300 636,900 574,500 483,700 409,300
Financial leverage ratio 1.46 1.42 1.41 1.40 1.39 1.39 1.41 1.54 1.51 1.50 1.53 1.53 1.54 1.87 1.82 1.94 2.05 2.05 2.21 2.34

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,251,400K ÷ $2,232,000K
= 1.46

The financial leverage ratio measures the extent to which a company relies on debt to finance its operations and growth. Neurocrine Biosciences' financial leverage ratio has been relatively stable in recent quarters, ranging from 1.39 to 1.46.

A financial leverage ratio of 1.46 in Q4 2023 indicates that for every dollar of equity, the company has $1.46 of total assets, with the difference financed by debt. This suggests that Neurocrine Biosciences has a moderate level of financial leverage, implying a reasonable level of risk associated with debt.

Overall, the trend in the financial leverage ratio for Neurocrine Biosciences has remained within a relatively narrow range, with a slight increase from 1.39 in Q4 2022 to 1.46 in Q4 2023. This stability indicates that the company has maintained a consistent capital structure in recent quarters. However, it would be beneficial for stakeholders to closely monitor any further changes in the ratio to ensure the company's financial health and ability to service its debt obligations effectively.


Peer comparison

Dec 31, 2023